Skip to main content
Top
Published in: Neurological Sciences 1/2013

01-05-2013 | ANIRCEF - HCNE JOINT MEETING

Closing remarks: what future prospects can we expect in migraine management?

Author: R. A. Purdy

Published in: Neurological Sciences | Special Issue 1/2013

Login to get access

Abstract

The future prospects that we can expect in migraine management are both exciting and challenging. Obviously, the future cannot be predicted fully; however, the science related to migraine pathogenesis, diagnosis and treatment has increased exponentially over the past two decades and continues to direct future research and clinical care. More than any time in the recent past, it now may be more possible to define better what migraine is and how it relates to other neurological disorders and other diseases. This overview will look at future prospects for management of migraine and how they relate to the migraine diathesis, and ways that might provide a better understanding of how it might be possible to calm the excitable brain. This meeting examined potential future developments in the management of migraine patients, with emphasis on disability, quality of life, and the role of patient personality in episodic and chronic migraine with substance/analgesic overuse. This meeting precedes the main theme of the seminar, which explores the relationships between pain, emotion and headache in light of recent findings, which show that pain and emotion are closely interrelated and contribute to the pathophysiology of headache. Thus, it is important to understand about future migraine management prospects in terms of known migraine pathophysiology, as current data provide support for the concept that migraine is a brain disorder.
Literature
2.
go back to reference Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341PubMedCrossRef Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341PubMedCrossRef
3.
go back to reference Sprenger T, Borsook D (2012) Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol 25:252–262PubMedCrossRef Sprenger T, Borsook D (2012) Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol 25:252–262PubMedCrossRef
4.
go back to reference Martin H, Sanchez del Rio M, de Silanes CL, Alvarez-Linera J, Hernandez JA et al (2011) Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level dependent in migraine patients and healthy volunteers: pathophysiological implications. Headache 51:1520–1528PubMedCrossRef Martin H, Sanchez del Rio M, de Silanes CL, Alvarez-Linera J, Hernandez JA et al (2011) Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level dependent in migraine patients and healthy volunteers: pathophysiological implications. Headache 51:1520–1528PubMedCrossRef
5.
go back to reference Charles A, Brennan KC (2009) Cortical spreading depression—new insights and persistent questions. Cephalalgia 29:1115–1124PubMedCrossRef Charles A, Brennan KC (2009) Cortical spreading depression—new insights and persistent questions. Cephalalgia 29:1115–1124PubMedCrossRef
7.
go back to reference Vincent MB, Hadjikhani N (2007) Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia 27:1368–1377PubMedCrossRef Vincent MB, Hadjikhani N (2007) Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia 27:1368–1377PubMedCrossRef
8.
go back to reference Schott GD (2007) Exploring the visual hallucinations of migraine aura: the tacit contribution of illustration. Brain 130:1690–1703PubMedCrossRef Schott GD (2007) Exploring the visual hallucinations of migraine aura: the tacit contribution of illustration. Brain 130:1690–1703PubMedCrossRef
9.
go back to reference Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675PubMedCrossRef Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675PubMedCrossRef
10.
go back to reference Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9:285–298PubMedCrossRef Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9:285–298PubMedCrossRef
11.
go back to reference Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C et al (2012) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78:1337–1345PubMedCrossRef Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C et al (2012) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78:1337–1345PubMedCrossRef
12.
go back to reference Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633–658PubMedCrossRef Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633–658PubMedCrossRef
13.
go back to reference Silberstein SD (2013) Emerging target-based paradigms to prevent and treat migraine. Clin Pharmacol Ther 93:78–85PubMedCrossRef Silberstein SD (2013) Emerging target-based paradigms to prevent and treat migraine. Clin Pharmacol Ther 93:78–85PubMedCrossRef
15.
go back to reference May A (2006) A review of diagnostic and functional imaging in headache. J Headache Pain 7:174–184PubMedCrossRef May A (2006) A review of diagnostic and functional imaging in headache. J Headache Pain 7:174–184PubMedCrossRef
16.
go back to reference DaSilva AF, Granziera C, Snyder J, Hadjikhani N (2007) Thickening in the somatosensory cortex of patients with migraine. Neurology 69:1990–1995PubMedCrossRef DaSilva AF, Granziera C, Snyder J, Hadjikhani N (2007) Thickening in the somatosensory cortex of patients with migraine. Neurology 69:1990–1995PubMedCrossRef
17.
go back to reference Granziera C, DaSilva AF, Snyder J, Tuch DS, Hadjikhani N (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3:e402PubMedCrossRef Granziera C, DaSilva AF, Snyder J, Tuch DS, Hadjikhani N (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3:e402PubMedCrossRef
18.
go back to reference Grazzi L, Chiapparini L, Ferraro S, Usai S, Andrasik F et al (2010) Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache 50:998–1004PubMedCrossRef Grazzi L, Chiapparini L, Ferraro S, Usai S, Andrasik F et al (2010) Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache 50:998–1004PubMedCrossRef
19.
go back to reference Borsook D, Maleki N, Becerra L, McEwen B (2012) Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron 73:219–234PubMedCrossRef Borsook D, Maleki N, Becerra L, McEwen B (2012) Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron 73:219–234PubMedCrossRef
20.
21.
go back to reference Tietjen GE, Herial NA, Hardgrove J, Utley C, White L (2007) Migraine comorbidity constellations. Headache 47:857–865PubMedCrossRef Tietjen GE, Herial NA, Hardgrove J, Utley C, White L (2007) Migraine comorbidity constellations. Headache 47:857–865PubMedCrossRef
22.
go back to reference Bigal ME, Lipton RB (2008) Clinical course in migraine: conceptualizing migraine transformation. Neurology 71:848–855PubMedCrossRef Bigal ME, Lipton RB (2008) Clinical course in migraine: conceptualizing migraine transformation. Neurology 71:848–855PubMedCrossRef
23.
go back to reference Sprenger T, Borsook D (2012) Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol 25:252–262PubMedCrossRef Sprenger T, Borsook D (2012) Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol 25:252–262PubMedCrossRef
24.
25.
go back to reference Raggi A, Giovannetti AM, Quintas R, D’Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M (2012) A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 13:595–606PubMedCrossRef Raggi A, Giovannetti AM, Quintas R, D’Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M (2012) A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 13:595–606PubMedCrossRef
26.
go back to reference Baskin SM, Smitherman TA (2009) Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61–S65PubMedCrossRef Baskin SM, Smitherman TA (2009) Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci 30(Suppl 1):S61–S65PubMedCrossRef
27.
go back to reference Ayata C (2009) Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 29:1097–1114CrossRef Ayata C (2009) Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 29:1097–1114CrossRef
28.
go back to reference Weeks RE (2009) Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations. Neurol Sci 30(Suppl 1):S95–S99PubMedCrossRef Weeks RE (2009) Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations. Neurol Sci 30(Suppl 1):S95–S99PubMedCrossRef
29.
go back to reference Andrasik F, Grazzi L, Usai S, D’Amico D, Kass S, Bussone G (2007) Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache 47(9):1277–1281PubMedCrossRef Andrasik F, Grazzi L, Usai S, D’Amico D, Kass S, Bussone G (2007) Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache 47(9):1277–1281PubMedCrossRef
Metadata
Title
Closing remarks: what future prospects can we expect in migraine management?
Author
R. A. Purdy
Publication date
01-05-2013
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2013
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-013-1361-5

Other articles of this Special Issue 1/2013

Neurological Sciences 1/2013 Go to the issue